These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytotoxic and genotoxic effects of high concentrations of the immunosuppressive drugs cyclosporine and tacrolimus in MRC-5 cells. Cilião HL; Ribeiro DL; Camargo-Godoy RB; Specian AF; Serpeloni JM; Cólus IM Exp Toxicol Pathol; 2015 Feb; 67(2):179-87. PubMed ID: 25541063 [TBL] [Abstract][Full Text] [Related]
4. Safety and toxicology of cyclosporine in propylene glycol after 9-month aerosol exposure to beagle dogs. Niven R; Lynch M; Moutvic R; Gibbs S; Briscoe C; Raff H J Aerosol Med Pulm Drug Deliv; 2011 Aug; 24(4):205-12. PubMed ID: 21476863 [TBL] [Abstract][Full Text] [Related]
5. Mutagenicity assessment strategy for pharmaceutical intermediates to aid limit setting for occupational exposure. Araya S; Lovsin-Barle E; Glowienke S Regul Toxicol Pharmacol; 2015 Nov; 73(2):515-20. PubMed ID: 26454093 [TBL] [Abstract][Full Text] [Related]
6. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study. Blot F; Tavakoli R; Sellam S; Epardeau B; Faurisson F; Bernard N; Becquemin MH; Frachon I; Stern M; Pocidalo JJ J Heart Lung Transplant; 1995; 14(6 Pt 1):1162-72. PubMed ID: 8719464 [TBL] [Abstract][Full Text] [Related]
7. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Dantal J; Hourmant M; Cantarovich D; Giral M; Blancho G; Dreno B; Soulillou JP Lancet; 1998 Feb; 351(9103):623-8. PubMed ID: 9500317 [TBL] [Abstract][Full Text] [Related]
8. [Comparative study on occupational exposure limits of chemical substances in workplace between GBZ 2.1 in China and ACGIH in USA]. Li W; Zhang M; Wang D Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2014 Jan; 32(1):1-26. PubMed ID: 24428986 [TBL] [Abstract][Full Text] [Related]
9. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]
11. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients. Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures. Proctor DM; Suh M; Campleman SL; Thompson CM Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529 [TBL] [Abstract][Full Text] [Related]
13. Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. Muellenhoff MW; Koo JY J Dermatolog Treat; 2012 Aug; 23(4):290-304. PubMed ID: 21936704 [TBL] [Abstract][Full Text] [Related]
14. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients. Gruber SA; Gillingham K; Sothern RB; Stephanian E; Matas AJ; Dunn DL Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545 [TBL] [Abstract][Full Text] [Related]